{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T11:25:47Z","timestamp":1696937147374},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1038\/s41390-020-0926-2","type":"journal-article","created":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T04:04:59Z","timestamp":1588305899000},"page":"510-517","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Induction of fecal cholesterol excretion is not effective for the treatment of hyperbilirubinemia in Gunn rats"],"prefix":"10.1038","volume":"89","author":[{"given":"Maaike","family":"Blankestijn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo P.","family":"van de Peppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ales","family":"Dvorak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Capkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libor","family":"Vitek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan W.","family":"Jonker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henkjan J.","family":"Verkade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"926_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molmed.2003.12.003","volume":"10","author":"JD Ostrow","year":"2004","unstructured":"Ostrow, J. D., Pascolo, L., Brites, D. & Tiribelli, C. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol. Med. 10, 65\u201370 (2004).","journal-title":"Trends Mol. Med."},{"key":"926_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/0006-2952(95)02224-4","volume":"51","author":"WM McDonnell","year":"1996","unstructured":"McDonnell, W. M., Hitomi, E. & Askari, F. K. Identification of bilirubin UDP-GTs in the human alimentary tract in accordance with the gut as a putative metabolic organ. Biochem. Pharmacol. 51, 483\u2013488 (1996).","journal-title":"Biochem. Pharmacol."},{"key":"926_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1152\/ajplegacy.1961.200.5.1091","volume":"200","author":"IM Arias","year":"1961","unstructured":"Arias, I. M., Johnson, L. & Wolfson, S. Biliary excretion of injected conjugated and unconjugated bilirubin by normal and Gunn rats. Am. J. Physiol. 200, 1091\u20131094 (1961).","journal-title":"Am. J. Physiol."},{"key":"926_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1203\/00006450-199708000-00011","volume":"42","author":"P Kotal","year":"1997","unstructured":"Kotal, P. et al. Intestinal excretion of unconjugated bilirubin in man and rats with inherited unconjugated hyperbilirubinemia. Pediatr. Res. 42, 195\u2013200 (1997).","journal-title":"Pediatr. Res."},{"key":"926_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1067\/S0022-3476(03)00298-1","volume":"143","author":"T Nishioka","year":"2003","unstructured":"Nishioka, T. et al. Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats. J. Pediatr. 143, 327\u2013334 (2003).","journal-title":"J. Pediatr."},{"key":"926_CR6","doi-asserted-by":"publisher","first-page":"673.e1","DOI":"10.1053\/j.gastro.2008.10.082","volume":"136","author":"FJC Cuperus","year":"2009","unstructured":"Cuperus, F. J. C. et al. Effective treatment of unconjugated hyperbilirubinemia with oral bile salts in Gunn rats. Gastroenterology 136, 673.e1\u2013682.e1 (2009).","journal-title":"Gastroenterology"},{"key":"926_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/j.gastro.2004.10.006","volume":"128","author":"JK Kruit","year":"2005","unstructured":"Kruit, J. K. et al. Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice. Gastroenterology 128, 147\u2013156 (2005).","journal-title":"Gastroenterology"},{"key":"926_CR8","doi-asserted-by":"publisher","first-page":"19211","DOI":"10.1074\/jbc.M109.014860","volume":"284","author":"JN van der Veen","year":"2009","unstructured":"van der Veen, J. N. et al. Activation of the liver X receptor stimulates trans-intestinal excretion of plasma cholesterol. J. Biol. Chem. 284, 19211\u201319219 (2009).","journal-title":"J. Biol. Chem."},{"key":"926_CR9","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cmet.2016.10.001","volume":"24","author":"L Jakulj","year":"2016","unstructured":"Jakulj, L. et al. Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion. Cell Metab. 24, 783\u2013794 (2016).","journal-title":"Cell Metab."},{"key":"926_CR10","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1194\/jlr.M800579-JLR200","volume":"50","author":"CLJ Vrins","year":"2009","unstructured":"Vrins, C. L. J. et al. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux. J. Lipid Res. 50, 2046\u20132054 (2009).","journal-title":"J. Lipid Res."},{"key":"926_CR11","doi-asserted-by":"crossref","first-page":"1126.e6","DOI":"10.1053\/j.gastro.2016.12.037","volume":"152","author":"JF de Boer","year":"2017","unstructured":"de Boer, J. F. et al. Intestinal farnesoid X receptor controls transintestinal cholesterol excretion in mice. Gastroenterology 152, 1126.e6\u20131138.e6 (2017).","journal-title":"Gastroenterology"},{"key":"926_CR12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.atherosclerosis.2012.02.014","volume":"222","author":"A Grefhorst","year":"2012","unstructured":"Grefhorst, A. et al. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol. Atherosclerosis 222, 382\u2013389 (2012).","journal-title":"Atherosclerosis"},{"key":"926_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.tem.2017.11.006","volume":"29","author":"JF de Boer","year":"2018","unstructured":"de Boer, J. F., Kuipers, F. & Groen, A. K. Cholesterol transport revisited: a new turbo mechanism to drive cholesterol excretion. Trends Endocrinol. Metab. 29, 123\u2013133 (2018).","journal-title":"Trends Endocrinol. Metab."},{"key":"926_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s11745-013-3790-6","volume":"48","author":"S Terunuma","year":"2013","unstructured":"Terunuma, S., Kumata, N. & Osada, K. Ezetimibe impairs uptake of dietary cholesterol oxidation products and reduces alterations in hepatic cholesterol metabolism and antioxidant function in rats. Lipids 48, 587\u2013595 (2013).","journal-title":"Lipids"},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1194\/jlr.M094607","volume":"60","author":"IP van de Peppel","year":"2019","unstructured":"van de Peppel, I. P. et al. Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in mice. J. Lipid Res. 60, 1562\u20131572 (2019).","journal-title":"J. Lipid Res."},{"key":"926_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1203\/01.pdr.0000203180.79636.98","volume":"59","author":"AM Hafkamp","year":"2006","unstructured":"Hafkamp, A. M. et al. Novel kinetic insights into treatment of unconjugated hyperbilirubinemia: phototherapy and orlistat treatment in Gunn rats. Pediatr. Res. 59, 506\u2013512 (2006).","journal-title":"Pediatr. Res."},{"key":"926_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hep.20589","volume":"41","author":"AM Hafkamp","year":"2005","unstructured":"Hafkamp, A. M., Havinga, R., Sinaasappel, M. & Verkade, H. J. Effective oral treatment of unconjugated hyperbilirubinemia in Gunn rats. Hepatology 41, 526\u2013534 (2005).","journal-title":"Hepatology"},{"key":"926_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1203\/PDR.0b013e31823240bc","volume":"70","author":"FJC Cuperus","year":"2011","unstructured":"Cuperus, F. J. C., Iemhoff, A. A. & Verkade, H. J. Combined treatment strategies for unconjugated hyperbilirubinemia in Gunn rats. Pediatr. Res 70, 560\u2013565 (2011).","journal-title":"Pediatr. Res"},{"key":"926_CR19","doi-asserted-by":"publisher","first-page":"G203","DOI":"10.1152\/ajpgi.90231.2008","volume":"295","author":"AE van der Velde","year":"2008","unstructured":"van der Velde, A. E. et al. Regulation of direct transintestinal cholesterol excretion in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G203\u2013G208 (2008).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"926_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.plipres.2012.11.001","volume":"52","author":"AC Bulmer","year":"2013","unstructured":"Bulmer, A. C., Verkade, H. J. & Wagner, K. H. Bilirubin and beyond: a review of lipid status in Gilbert\u2019s syndrome and its relevance to cardiovascular disease protection. Prog. Lipid Res. 52, 193\u2013205 (2013).","journal-title":"Prog. Lipid Res."},{"key":"926_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/cpmo.16","volume":"6","author":"OAHO Ronda","year":"2016","unstructured":"Ronda, O. A. H. O., van Dijk, T. H., Verkade, H. J. & Groen, A. K. Measurement of intestinal and peripheral cholesterol fluxes by a dual-tracer balance method. Curr. Protoc. Mouse Biol. 6, 408\u2013434 (2016).","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"926_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh, E. G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911\u2013917 (1959).","journal-title":"Can. J. Biochem. Physiol."},{"key":"926_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0022-2275(20)38331-0","volume":"30","author":"DM Heuman","year":"1989","unstructured":"Heuman, D. M. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J. Lipid Res. 30, 719\u2013730 (1989).","journal-title":"J. Lipid Res."},{"key":"926_CR24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/hep.28712","volume":"64","author":"Y Xu","year":"2016","unstructured":"Xu, Y. et al. Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice. Hepatology 64, 1072\u20131085 (2016).","journal-title":"Hepatology"},{"key":"926_CR25","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1124\/jpet.112.196519","volume":"343","author":"E Hambruch","year":"2012","unstructured":"Hambruch, E. et al. Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor. J. Pharmacol. Exp. Ther. 343, 556\u2013567 (2012).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"926_CR26","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1210\/en.2013-2143","volume":"155","author":"T Sugizaki","year":"2014","unstructured":"Sugizaki, T. et al. The Niemann-Pick C1 Like 1 (NPC1L1) inhibitor ezetimibe improves metabolic disease via decreased liver X receptor (LXR) activity in liver of obese male mice. Endocrinology 155, 2810\u20132819 (2014).","journal-title":"Endocrinology"},{"key":"926_CR27","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ajh.23623","volume":"89","author":"AWY Shih","year":"2014","unstructured":"Shih, A. W. Y., McFarlane, A. & Verhovsek, M. Haptoglobin testing in hemolysis: measurement and interpretation. Am. J. Hematol. 89, 443\u2013447 (2014).","journal-title":"Am. J. Hematol."},{"key":"926_CR28","doi-asserted-by":"publisher","first-page":"e0152207","DOI":"10.1371\/journal.pone.0152207","volume":"11","author":"T Nakano","year":"2016","unstructured":"Nakano, T. et al. Ezetimibe promotes brush border membrane-to-lumen cholesterol efflux in the small intestine. PLoS ONE 11, e0152207 (2016).","journal-title":"PLoS ONE"},{"key":"926_CR29","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/sj.bjp.0703235","volume":"129","author":"M Van Heek","year":"2000","unstructured":"Van Heek, M. et al. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br. J. Pharmacol. 129, 1748\u20131754 (2000).","journal-title":"Br. J. Pharmacol."},{"key":"926_CR30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1124\/dmd.32.3.314","volume":"32","author":"A Ghosal","year":"2004","unstructured":"Ghosal, A. et al. Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab. Dispos. 32, 314\u2013320 (2004).","journal-title":"Drug Metab. Dispos."},{"key":"926_CR31","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1194\/jlr.M700470-JLR200","volume":"49","author":"L Calpe-Berdiel","year":"2008","unstructured":"Calpe-Berdiel, L. et al. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5\/G8. J. Lipid Res. 49, 1904\u20131911 (2008).","journal-title":"J. Lipid Res."},{"key":"926_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.plipres.2010.03.002","volume":"49","author":"MH Oosterveer","year":"2010","unstructured":"Oosterveer, M. H., Grefhorst, A., Groen, A. K. & Kuipers, F. The liver X receptor: control of cellular lipid homeostasis and beyond. Prog. Lipid Res. 49, 343\u2013352 (2010).","journal-title":"Prog. Lipid Res."},{"key":"926_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jsbmb.2011.06.012","volume":"130","author":"JW Jonker","year":"2012","unstructured":"Jonker, J. W., Liddle, C. & Downes, M. FXR and PXR: potential therapeutic targets in cholestasis. J. Steroid Biochem. Mol. Biol. 130, 147\u2013158 (2012).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"926_CR34","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/hep.510240326","volume":"24","author":"CN Van Der Veere","year":"1996","unstructured":"Van Der Veere, C. N. et al. Influence of dietary calcium phosphate on the disposition of bilirubin in rats with unconjugated hyperbilirubinemia. Hepatology 24, 620\u2013626 (1996).","journal-title":"Hepatology"},{"key":"926_CR35","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.bbrc.2005.12.137","volume":"340","author":"C Duval","year":"2006","unstructured":"Duval, C. et al. Niemann\u2013Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem. Biophys. Res. Commun. 340, 1259\u20131263 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"926_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s13318-015-0269-2","volume":"41","author":"A Kawase","year":"2016","unstructured":"Kawase, A., Araki, Y., Ueda, Y., Nakazaki, S. & Iwaki, M. Impact of a high-cholesterol diet on expression levels of Niemann-Pick C1-like 1 and intestinal transporters in rats and mice. Eur. J. Drug Metab. Pharmacokinet. 41, 457\u2013463 (2016).","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"926_CR37","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1373\/clinchem.2005.058644","volume":"51","author":"G Dimeski","year":"2005","unstructured":"Dimeski, G., Mollee, P. & Carter, A. Increased lipid concentration is associated with increased hemolysis. Clin. Chem. 51, 2425 (2005).","journal-title":"Clin. Chem."},{"key":"926_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0021-9258(19)51154-1","volume":"184","author":"IM London","year":"1950","unstructured":"London, I. M., West, R., Shemin, D. & Rittenberg, D. On the origin of bile pigment in normal man. J. Biol. Chem. 184, 351\u2013358 (1950).","journal-title":"J. Biol. Chem."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-020-0926-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-020-0926-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-020-0926-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:17Z","timestamp":1684618277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-020-0926-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1038\/s41390-020-0926-2","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"22 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}